Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin Reversal With Two Different Protamine Ratios
NCT06154018Completed
- Sponsor
- University of Ioannina
- Start
- Mar 2023
- Primary completion
- Apr 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of protamine in coagulation disorder (2 arms), sponsored by University of Ioannina. Primary endpoints: Activated Clotting Time and Viscoelastic testing (Clot-Pro). Started Mar 2023; status: completed.
02
Drugs
protamine
03
Conditions
coagulation disorder
Beyond the preview
Go deeper on NCT06154018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06154018.